Nelson Michael D
Applied Physiology and Advanced Imaging Laboratory, University of Texas at Arlington, Arlington, Texas
Am J Physiol Regul Integr Comp Physiol. 2017 Oct 1;313(4):R322-R329. doi: 10.1152/ajpregu.00249.2017. Epub 2017 Aug 9.
Ischemic heart disease, in the absence of obstructive coronary artery disease, is prevalent in women and constitutes a major risk factor for developing major adverse cardiovascular events, including myocardial infarction, stroke, and heart failure. For decades, diagnosis was considered benign and often minimized; however, it is now known that this etiology carries much risk and is a significant burden to the health care system. This review summarizes the current state of knowledge on nonobstructive ischemic heart disease (NOIHD), the association between NOIHD and left ventricular diastolic dysfunction, potential links between NOIHD and the development of heart failure with preserved ejection fraction (HFpEF), and therapeutic options and knowledge gaps for patients living with NOIHD.
在无阻塞性冠状动脉疾病的情况下,缺血性心脏病在女性中很常见,并且是发生包括心肌梗死、中风和心力衰竭在内的主要不良心血管事件的主要危险因素。几十年来,这种疾病被认为是良性的,其诊断往往被轻视;然而,现在人们知道这种病因存在很大风险,并且给医疗保健系统带来了重大负担。本综述总结了关于非阻塞性缺血性心脏病(NOIHD)的当前知识状况、NOIHD与左心室舒张功能障碍之间的关联、NOIHD与射血分数保留的心力衰竭(HFpEF)发展之间的潜在联系,以及NOIHD患者的治疗选择和知识空白。